Logo image of INNV

INNOVAGE HOLDING CORP (INNV) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:INNV - US45784A1043 - Common Stock

5.32 USD
0 (0%)
Last: 11/25/2025, 8:00:02 PM
5.32 USD
0 (0%)
After Hours: 11/25/2025, 8:00:02 PM
Fundamental Rating

4

INNV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. INNV has a great financial health rating, but its profitability evaluates not so good. INNV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year INNV has reported negative net income.
In the past year INNV had a positive cash flow from operations.
In the past 5 years INNV always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: INNV reported negative operating cash flow in multiple years.
INNV Yearly Net Income VS EBIT VS OCF VS FCFINNV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

1.2 Ratios

With a Return On Assets value of -3.40%, INNV is not doing good in the industry: 63.37% of the companies in the same industry are doing better.
INNV has a Return On Equity of -7.09%. This is comparable to the rest of the industry: INNV outperforms 45.54% of its industry peers.
Industry RankSector Rank
ROA -3.4%
ROE -7.09%
ROIC N/A
ROA(3y)-5.61%
ROA(5y)-5.25%
ROE(3y)-11.52%
ROE(5y)-9.93%
ROIC(3y)N/A
ROIC(5y)N/A
INNV Yearly ROA, ROE, ROICINNV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

INNV has a worse Gross Margin (19.27%) than 61.39% of its industry peers.
In the last couple of years the Gross Margin of INNV has declined.
INNV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.44%
GM growth 5Y-6.3%
INNV Yearly Profit, Operating, Gross MarginsINNV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 20

7

2. Health

2.1 Basic Checks

INNV does not have a ROIC to compare to the WACC, probably because it is not profitable.
INNV has less shares outstanding than it did 1 year ago.
INNV has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, INNV has an improved debt to assets ratio.
INNV Yearly Shares OutstandingINNV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
INNV Yearly Total Debt VS Total AssetsINNV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 3.15 indicates that INNV is not in any danger for bankruptcy at the moment.
The Altman-Z score of INNV (3.15) is better than 63.37% of its industry peers.
The Debt to FCF ratio of INNV is 1.95, which is an excellent value as it means it would take INNV, only 1.95 years of fcf income to pay off all of its debts.
INNV has a Debt to FCF ratio of 1.95. This is amongst the best in the industry. INNV outperforms 85.15% of its industry peers.
INNV has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
INNV has a better Debt to Equity ratio (0.25) than 69.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 1.95
Altman-Z 3.15
ROIC/WACCN/A
WACC8.76%
INNV Yearly LT Debt VS Equity VS FCFINNV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.17 indicates that INNV should not have too much problems paying its short term obligations.
INNV has a Current ratio (1.17) which is in line with its industry peers.
INNV has a Quick Ratio of 1.17. This is a normal value and indicates that INNV is financially healthy and should not expect problems in meeting its short term obligations.
INNV has a Quick ratio (1.17) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
INNV Yearly Current Assets VS Current LiabilitesINNV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.00% over the past year.
The Revenue has grown by 12.48% in the past year. This is quite good.
Measured over the past years, INNV shows a quite strong growth in Revenue. The Revenue has been growing by 8.52% on average per year.
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)12.48%
Revenue growth 3Y6.91%
Revenue growth 5Y8.52%
Sales Q2Q%15.09%

3.2 Future

The Earnings Per Share is expected to grow by 77.26% on average over the next years. This is a very strong growth
INNV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.21% yearly.
EPS Next Y195.62%
EPS Next 2Y101.79%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue Next Year8.7%
Revenue Next 2Y9.18%
Revenue Next 3Y9.21%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
INNV Yearly Revenue VS EstimatesINNV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INNV Yearly EPS VS EstimatesINNV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -5 -10 -15

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INNV. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 16.05, INNV is valued correctly.
76.24% of the companies in the same industry are more expensive than INNV, based on the Price/Forward Earnings ratio.
INNV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.79.
Industry RankSector Rank
PE N/A
Fwd PE 16.05
INNV Price Earnings VS Forward Price EarningsINNV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

INNV's Enterprise Value to EBITDA ratio is in line with the industry average.
65.35% of the companies in the same industry are more expensive than INNV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20
EV/EBITDA 39.22
INNV Per share dataINNV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INNV's earnings are expected to grow with 77.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y101.79%
EPS Next 3Y77.26%

0

5. Dividend

5.1 Amount

No dividends for INNV!.
Industry RankSector Rank
Dividend Yield N/A

INNOVAGE HOLDING CORP

NASDAQ:INNV (11/25/2025, 8:00:02 PM)

After market: 5.32 0 (0%)

5.32

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-02 2026-02-02
Inst Owners12.08%
Inst Owner Change-0.6%
Ins Owners1.96%
Ins Owner Change0.34%
Market Cap721.60M
Revenue(TTM)884.66M
Net Income(TTM)-17.36M
Analysts45
Price Target6.12 (15.04%)
Short Float %1.22%
Short Ratio2.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)273.11%
Min EPS beat(2)57.98%
Max EPS beat(2)488.24%
EPS beat(4)2
Avg EPS beat(4)-68.35%
Min EPS beat(4)-527.45%
Max EPS beat(4)488.24%
EPS beat(8)4
Avg EPS beat(8)-20.2%
EPS beat(12)5
Avg EPS beat(12)-33.17%
EPS beat(16)5
Avg EPS beat(16)-65.91%
Revenue beat(2)1
Avg Revenue beat(2)0.46%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)2.15%
Revenue beat(4)1
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)2.15%
Revenue beat(8)4
Avg Revenue beat(8)0.06%
Revenue beat(12)5
Avg Revenue beat(12)-0.53%
Revenue beat(16)6
Avg Revenue beat(16)-0.63%
PT rev (1m)2.86%
PT rev (3m)5.88%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)300%
EPS NY rev (1m)0%
EPS NY rev (3m)200%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.05
P/S 0.82
P/FCF 20
P/OCF 16.32
P/B 2.95
P/tB 7.27
EV/EBITDA 39.22
EPS(TTM)-0.06
EYN/A
EPS(NY)0.33
Fwd EY6.23%
FCF(TTM)0.27
FCFY5%
OCF(TTM)0.33
OCFY6.13%
SpS6.52
BVpS1.81
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.4%
ROE -7.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.27%
FCFM 4.08%
ROA(3y)-5.61%
ROA(5y)-5.25%
ROE(3y)-11.52%
ROE(5y)-9.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.44%
GM growth 5Y-6.3%
F-Score6
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 1.95
Debt/EBITDA 3.83
Cap/Depr 42.43%
Cap/Sales 0.92%
Interest Coverage N/A
Cash Conversion 270.83%
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 3.15
F-Score6
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)75.1%
Cap/Depr(5y)131.8%
Cap/Sales(3y)1.72%
Cap/Sales(5y)2.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y195.62%
EPS Next 2Y101.79%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue 1Y (TTM)12.48%
Revenue growth 3Y6.91%
Revenue growth 5Y8.52%
Sales Q2Q%15.09%
Revenue Next Year8.7%
Revenue Next 2Y9.18%
Revenue Next 3Y9.21%
Revenue Next 5YN/A
EBIT growth 1Y83.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year295.43%
EBIT Next 3Y71.46%
EBIT Next 5YN/A
FCF growth 1Y181.77%
FCF growth 3YN/A
FCF growth 5Y-3.62%
OCF growth 1Y270.88%
OCF growth 3Y6.38%
OCF growth 5Y-5.59%

INNOVAGE HOLDING CORP / INNV FAQ

Can you provide the ChartMill fundamental rating for INNOVAGE HOLDING CORP?

ChartMill assigns a fundamental rating of 4 / 10 to INNV.


Can you provide the valuation status for INNOVAGE HOLDING CORP?

ChartMill assigns a valuation rating of 5 / 10 to INNOVAGE HOLDING CORP (INNV). This can be considered as Fairly Valued.


What is the profitability of INNV stock?

INNOVAGE HOLDING CORP (INNV) has a profitability rating of 1 / 10.